Home gilead
 

Keywords :   


Tag: gilead

Gilead Sciences halts drug studies over side effects, death

2016-03-15 23:33:19| Biotech - Topix.net

Biologic drugmaker Gilead Sciences Inc. has halted several patient studies of its cancer drug, Zydelig, because of increased risk of death and serious side effects. The company told The Associated Press the "adverse events" were spotted during an ongoing review of late-stage testing in patients with chronic lymphocytic leukemia, a blood cancer, and patients with relapsed non-Hodgkin's lymphoma, a cancer of the infection-fighting lymphatic system.

Tags: side death effects studies

 

Gilead: Your Biggest Consideration

2016-03-14 06:47:01| Biotech - Topix.net

The EBITDA to EV ratio has been growing for two straight years, nearly doubling from 44% to 72%, showing increasing momentum in the company. Late last month, I exited my long position on Gilead .

Tags: consideration biggest gilead

 
 

UPDATE 1-Infection worries prompt regulatory reviews of Gilead leukaemia drug

2016-03-12 05:33:35| Biotech - Topix.net

European and U.S. regulators are reviewing the safety of Gilead Sciences' leukaemia drug Zydelig due to concerns over serious adverse events, including deaths. The actions were prompted by an increased rate of harmful events, mostly due to infections, seen in three clinical trials that tested the drug in combination with other cancer medicines, the European Medicines Agency said on Friday.

Tags: reviews update drug regulatory

 

Merck Demands $3 Billion In HCV Royalties From Gilead

2016-03-11 20:20:18| Biotech - Topix.net

Merck wants to Bogart a $3B royalty payment equal to 10% of the $31.7B Gilead has made from HCV sales. Gilead has had a target on its back from regulators, competitors and politicians ever since its blockbuster HCV regimen hit the market.

Tags: billion demands merck royalties

 

Florida man pleads guilty in Gilead insider trading case

2016-03-10 00:22:27| Biotech - Topix.net

A Florida man admitted to conducting insider trading based on a tip he received from a former Morgan Stanley broker about Gilead Sciences Inc's planned $11.2 billion purchase of Pharmasset Inc in 2011, federal prosecutors said. Jay Fung, 42, of Delray Beach, pleaded guilty on Wednesday to conspiracy to commit securities fraud before U.S. District Judge Anne Thompson in Trenton, New Jersey.

Tags: man case florida trading

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »